Clinical Trial Update: Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating immune checkpoint blockade therapy with 18F-FLT PET/CT has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: Cancer | Phase 2 | Status: WITHDRAWN